Target intelligence / Profile preview

Mycobacterial antigen presentation enhancement via phagolysosomal escape

Molecular classification
Other, Bacterial virulence mechanism
01

Overview

"Mycobacterial antigen presentation enhancement via phagolysosomal escape" describes a process by which Mycobacterium tuberculosis (Mtb) evades macrophage killing by escaping from the phagosome into the cytosol of the host cell. This escape, mediated by factors like the ESX-1 secretion system and ESAT-6 protein, enables bacterial antigens to access the cytosolic major histocompatibility complex class I (MHC-I) processing pathway and impacts both pathogen survival and host immune recognition. The process enhances mycobacterial virulence, supports immune evasion, and modulates how antigens are presented to T cells, but is not a targetable molecule in itself[1][2][3][4][6].

Other names
Mycobacterial phagosomal escapeMtb cytosolic translocationPhagosome rupture by Mycobacterium tuberculosis
02

Mechanism of action

Enhancement or inhibition of mycobacterial ESX-1/ESAT-6 secretion system may modulate escape and antigen presentation. Phagosome maturation promotion (general immunomodulatory strategies). No drugs act directly on the process named here; this is a general immunological concept rather than a ligand–receptor or enzyme–inhibitor interaction.

03

Biological functions

Immune evasionAntigen presentation modulationIntracellular survivalVirulence enhancementPromotion of macrophage necrosis
04

Disease associations

Infection (specifically tuberculosis pathogenesis)Immune evasion in chronic infection
05

Safety considerations

Targeting this process generally risks host cell toxicity or disruption of normal phagocytosis/autophagyPotential for non-specific immune activation leading to inflammation or tissue damageTherapeutic manipulation is investigational and may affect essential host defense mechanisms

Beyond the preview

Go deeper on Mycobacterial antigen presentation enhancement via phagolysosomal escape.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterial antigen presentation enhancement via phagolysosomal escape.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call